Tag Archives: Shan5™

Sanofi Pasteur announced its pediatric pentavalent vaccine Shan5™ received prequalification status from the World Health Organization

Shan5™ is the first vaccine jointly developed by the Indian company and its parent company Sanofi Pasteur  WHO’s decision allows for the purchase of Shan5™ by United Nations agencies Lyon, France, 7-5-2014 — /EuropaWire/ — Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: … Read the full press release